4//SEC Filing
Nunes Anne 4
Accession 0001171843-24-001305
CIK 0000898437other
Filed
Mar 11, 8:00 PM ET
Accepted
Mar 12, 8:02 PM ET
Size
15.5 KB
Accession
0001171843-24-001305
Insider Transaction Report
Form 4
Nunes Anne
SVP, Chief Operations Officer
Transactions
- Exercise/Conversion
Common Stock
2024-03-11+3,295→ 10,245 total - Tax Payment
Common Stock
2024-03-11$25.42/sh−968$24,607→ 9,277 total - Exercise/Conversion
Common Stock
2024-03-11+2,561→ 11,838 total - Tax Payment
Common Stock
2024-03-11$25.79/sh−752$19,394→ 11,086 total - Exercise/Conversion
Restricted Stock Unit
2024-03-11−3,295→ 6,591 totalExercise: $0.00→ Common Stock (3,295 underlying) - Exercise/Conversion
Restricted Stock Unit
2024-03-11−2,561→ 2,561 totalExercise: $0.00→ Common Stock (2,561 underlying)
Footnotes (10)
- [F1]Reflects the first vesting installment of RSUs granted on March 9, 2023.
- [F10]Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 11, 2023.
- [F2]Reflects the corrected Amount of Shares Beneficially Owned under Table I, Column 2 as reported in Form 3/A filed by the Reporting Person on January 12, 2024.
- [F3]Includes 414 shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan on November 14, 2023.
- [F4]Reflects an aggregate of 968 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2024.
- [F5]Reflects the closing price of ANIK common stock on March 8, 2024, the trading day prior to which the vesting of RSUs gave rise to tax withholding obligations.
- [F6]Reflects the second vesting installment of RSUs granted on March 11, 2022.
- [F7]Reflects an aggregate of 752 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 11, 2024.
- [F8]Reflects the closing price of ANIK common stock on March 11, 2024, the trading day on which the vesting of RSUs gave rise to tax withholding obligations.
- [F9]Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2024.
Documents
Issuer
Anika Therapeutics, Inc.
CIK 0000898437
Entity typeother
Related Parties
1- filerCIK 0001982862
Filing Metadata
- Form type
- 4
- Filed
- Mar 11, 8:00 PM ET
- Accepted
- Mar 12, 8:02 PM ET
- Size
- 15.5 KB